EMX does not plan to raise equity capital or sell royalties at current valuations; the company will only engage in transformational transactions if counterparties offer substantially more than current NAV, and the stated long-term objective is achieving 17-18% compounded annual growth rate in share price through organic cash flow growth and strategic capital allocation.